Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women
- PMID: 3465310
- DOI: 10.1111/j.1445-5994.1986.tb01183.x
Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women
Abstract
Osteoporosis is a common complication of corticosteroid therapy and it is associated with both decreased bone formation and increased bone resorption. We have measured radiocalcium absorption and the fasting urinary calcium/creatinine and hydroxyproline/creatinine ratios in 30 postmenopausal women receiving prednisolone therapy and compared the patients with normal spine radiographs (N = 14) with those whose spine radiographs showed osteoporosis (N = 16). The osteoporotic cases had lower radiocalcium absorption (p less than 0.001), higher fasting urinary calcium (p less than 0.05), and higher fasting urinary hydroxyproline excretion (p less than 0.001). As calcium absorption has a positive effect on calcium balance and urinary calcium a negative effect, the difference between these two variables was calculated in each case. This derived variable (radiocalcium absorption--fasting urinary calcium/creatinine) disclosed a greater difference between the osteoporotic and normal groups (p less than 0.0001) than either variable alone.
Similar articles
-
Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women.Calcif Tissue Int. 1987 Jul;41(1):7-10. doi: 10.1007/BF02555124. Calcif Tissue Int. 1987. PMID: 3113703
-
Effect of salt restriction on urine hydroxyproline excretion in postmenopausal women.Arch Intern Med. 1991 Apr;151(4):757-9. Arch Intern Med. 1991. PMID: 2012460
-
Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women.Am J Clin Nutr. 1984 Jun;39(6):857-9. doi: 10.1093/ajcn/39.6.857. Am J Clin Nutr. 1984. PMID: 6720619 Clinical Trial.
-
Biochemical effects of calcium supplementation in postmenopausal osteoporosis.Eur J Clin Nutr. 1988 Sep;42(9):775-8. Eur J Clin Nutr. 1988. PMID: 3181110
-
Calcium and osteoporosis.Ann Chir Gynaecol. 1988;77(5-6):212-8. Ann Chir Gynaecol. 1988. PMID: 3076047 Review.
Cited by
-
The effect of long- and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels.Calcif Tissue Int. 1994 Mar;54(3):198-202. doi: 10.1007/BF00301678. Calcif Tissue Int. 1994. PMID: 8055366
-
Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study.Osteoporos Int. 1993 Mar;3(2):97-102. doi: 10.1007/BF01623380. Osteoporos Int. 1993. PMID: 8453197
-
Corticosteroid-Induced osteoporosis: detection and management.Drug Saf. 2001;24(8):607-24. doi: 10.2165/00002018-200124080-00005. Drug Saf. 2001. PMID: 11480493 Review.
-
Malabsorption of calcium in corticosteroid-induced osteoporosis.Calcif Tissue Int. 1990 May;46(5):305-8. doi: 10.1007/BF02563820. Calcif Tissue Int. 1990. PMID: 2110853
-
Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover.Eur J Clin Pharmacol. 1991;40(1):77-82. doi: 10.1007/BF00315143. Eur J Clin Pharmacol. 1991. PMID: 2060551 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials